Akebia Therapeutics Inc
(NAS:AKBA)
$
0.89
+0.027 (+3.11%)
Market Cap: 247.51 Mil
Enterprise Value: 146.93 Mil
PE Ratio: 0
PB Ratio: 9.71
GF Score: 47/100 Akebia Therapeutics Inc (AKBA) Transcripts
- 1